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BACKGROUND: Adenosine Deaminase, the key enzyme of 
purine metabolism catalyzing the irreversible hydrolytic 
deamination of adenosine to inosine is implicated in a varied 
spectrum of human diseases ranging from SCID to TB and 
pneumonia. Estimation of ADA offers an easy, relatively 
affordable and reliable diagnostic alternative and/ or adjunct 
(specially in a TB endemic nation) which emphasizes the 
necessity of a feasible and implementable alternative method 
to the Diazyme method of ADA estimation requiring high end 
autoanalyzer and infrastructural setup. 
METHODS: Sixty body fluids samples (irrespective of 
gender, age, diagnosis or sample type) received by the 
Clinical Biochemistry Laboratory, Kasturba Medical College, 
Manipal for fluid ADA estimation by the Diazyme assay 
method (cobas 6000) was simultaneously processed by the 
Galanti and Guisti manual method to estimate the 
comparability and the aggregability of results obtained by the 
two analytical techniques. 
RESULTS: The Galanti and Guisti manual method of ADA 
estimation showed aggregability with the Diazyme 
autoanalyzer method for 90% of the assayed study samples 
with the manual method uniformly showing higher values 
when compared to the analyzer method. A correction factor 
of 2.44 was arrived at which could effectively achieve 
comparability between the two assay methods. 
CONCLUSION: The Galanti and Guisti manual method of 
ADA estimation might be a feasible, rapid, reliable and cost-
effective method for estimation of fluid ADA when compared 
to the cost and infrastructure intensive autoanalyzer. 
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Adenosine Deaminase (Adenosine 
aminohydrolase EC 3.5.4.4) is an enzyme of 
purine metabolism which catalyses the 
irreversible hydrolytic deamination of 
adenosine to inosine and ammonia (1). ADA 
is the key enzyme of purine metabolism 
with a high degree of conserved amino acid 
sequence which suggests the essential and 
indispensable role of ADA in the purine 
salvage pathway (2). ADA is a ubiquitously 
expressed enzyme with its major activity 
localized in the cytosolic compartment (only 
3% in subcellular organelles) and the highest 
activities recorded in the lymphoid tissues, 
particularly the thymus, the brain, spleen and the 
gastrointestinal tract (1,3).  
ADA is involved in the development and 
maintenance of the immune system as it ensures 
the breakdown of metabolic by-products toxic to 
T-lymphocytes, in absence of which the toxic 
by-products of purine metabolism kill the T cells 
shortly after they are produced in the bone 
marrow, greatly reducing the number of T cells 
and resulting in ADA dependent severe acute 
combined immunodeficiency (SCID) (3). Whilst 
most notable affects are on lymphocytes, given 
the ubiquitous nature of the enzyme, several 
non-immunological manifestations including 
neurodevelopmental deficits, pulmonary 
manifestations associated with pulmonary-
alveolar proteinosis, sensorineural deafness and 
skeletal abnormalities are observed (3). ADA 
has also been associated with epithelial cell 
differentiation, neurotransmission, maintenance 
of gestation, stimulation of the release of 
excitatory amino acids and the coupling of A1 
adenosine receptors and heterotrimeric G 
proteins (2,4). While elevated levels of ADA 
have been associated with typhoid fever, 
infectious mononucleosis, tuberculous 
meningitis (differentiates tuberculous from viral 
lymphocytic meningitis), AIDS, rheumatoid 
arthritis, psoriasis, pneumonia, chronic diarrhoea 
and widespread skin rashes (5). Assessment of 
ADA in pathologic fluids has been found to be 
of immense value in the diagnosis of 
tuberculosis, a common communicable 
condition affecting a significant number of 
individuals across the globe (6). Estimation of 
pleural fluid ADA could be easy, cheap 
diagnostic alternative offering high sensitivity 
and specificity test for diagnosis of TB pleural 
effusion and circumventing the need for pleural 
biopsy to ascertain the diagnosis of TB about 
40% of the patient population (7,8). 
Given the wide range of functions, the 
biochemical estimation and quantification of 
ADA is a diagnostic and prognostic aid to a 
myriad clinical condition. However, estimation 
of ADA remains a cost-intensive infrastructural 
hurdle in resource constrained rural predominant 
settings of India, where approximately 2.69 
million TB cases and 9700 deaths associated 
with TB are reported annually, the country being 
the leading contributor to the global burden of 
TB (9,10). According to the World Health 
Organisation, 30 countries accounted for 87% of 
new TB cases in the year 2018, with eight 
countries accounting for two thirds of the global 
burden and India being the leading contributor 
of the global burden (10). Thus, it is clear that 
tuberculosis still remains a public health hazard 
in India with an estimated 40% of the Indian 
population being infected with TB bacteria; the 
vast majority of whom have latent TB rather 
than TB disease (9,11). However, with rapid 
diagnosis and interventions, TB is indeed 
curable and preventable too. Identification of TB 
in body fluid still remains a challenging area in 
diagnostics with fluid ADA activity offering a 
welcome diagnostic alternative and adjunct for 
diagnosis of TB, estimation of ADA being 
comparatively inexpensive, non-invasive, less 
time consuming and reliable (12). Literature 
evidences have proved its utility of ADA in the 
diagnosis of TB with the hypothesis that the 
observed increase in ADA activity is possibly 
due to delayed hypersensitivity reaction to 
mycobacterial antigen (12-14). ADA with its 
relative ease of sampling requirement, assay and 
speed of result availability (on the same day 
compared 2 weeks required for culture) indeed 
offers an immense potential as an adjunct 
diagnostic tool for TB (associated forms and 
conditions) and other ADA related pathologies 
like SCID, allowing rapid institution of 
treatment leading to reduction in complication 
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and improvement in patient outcome (15). This 
dictates the imperative need of a feasible and 
implementable alternative to the diazyme (kit) 
method (using 6000 autoanalyzer platform) of 
ADA estimation which could help in fast 
tracking the diagnosis of ADA implicated 
diseases and also ensure cost management in 
terms of reduced need of sample outsourcing 
and testing services to distant laboratories.  
Thus, we aim to evaluate the diagnostic 
efficiency of the cost-effective age old Galanti 
and Guisti manual method of ADA estimation 
and compare the accuracy of this method with 
the cost intensive, high end infrastructure 




The study was approved by the Institutional 
Ethical Committee and carried out in the 
Department of Biochemistry for a period of six 
months.  Sixty samples of body fluids received 
by the Clinical Biochemistry Laboratory 
(physician requested ADA estimation) was 
included in the study; no additional body fluid 
samples were collected. All samples received for 
ADA estimation were included in the study 
regardless of gender, age, diagnosis or the type 
of sample (CSF, pleural, ascitic). As per the 
standard operating protocol of the laboratory, all 
the fluid samples were analysed by the routine 
diazyme ADA assay by cobas 6000 (Roche 
diagnostics). Residual fluid samples were used 
for ADA estimation by the manual Galanati and 
Guisti method to assess the comparability 
between the two methods. Further, relevant 
haematological and biochemical laboratory 
findings were retrieved through the Laboratory 
Information System.  Clinical history, and 
diagnostic details of the patients were obtained 
from patient records stored in the Medical 
Records Department of the hospital. 
Confidentiality of patient was respected and 
uncompromised during the entire study. 
 
Statistical Analysis: Mean difference, bias, 
Standard Deviation and the upper and lower 
limits of agreement were determined. A Band 
Altman plot was generated to estimate the 
degree of agreement between the two analytical 
methods. Linear regression analysis was carried 
out to generate the regression equation for the 
two assay methods. 
 
RESULTS 
The ADA values obtained from both the 
assay method (analyser and manual method) 
were recorded. It was observed that the 
manual Galanti and Guisti method of ADA 
estimation uniformly showed higher values 
for ADA when compared to the values 
generated by the analyser method. We 
arrived at a correction factor of 2.44 to 
achieve comparability between the two 
assay methods. Therefore, diving the results 
obtained from Galanti and Guisti method by 
a factor of 2.44, could approximately 
provide a value similar to  that obtained 
from the Diazyme autoanalyzer assay 
method.  
Further, the mean difference, bias, 
Standard Deviation and the upper and lower 
limits of agreement were determined. The 
results obtained from the two methods were 
compared to assess the agreement between 
the two methods of estimation. A Band 
Altman plot was generated to estimate the 
degree of agreement. As shown in Figure 1, 
90% of the assayed samples showed 
agreeable results between the two methods 
while only a meagre 10% of the samples  
did not fall within the degree of agreement 
when analysed by the two methods. Samples 
showing very high or very low autoanalyzer 
values tend to show divergence from the 
expected manual values. Additionally, 
according to our observation, 71.4% of the 
divergence was contributed by pleural fluid 
samples (cases of pleural effusion and 
multisystem inflammatory syndrome 
secondary to bronchopneumonia 
with/without AKI/ hepatitis/ COPD) and 
28.5% (focal dyscognitive seizures and 
neurobrucellosis) of the divergence was 








accounted for by CSF samples, while none 
of the serum ADA showed such a 
divergence between the two assay methods. 
Further, a linear regression was calculated to 
predict autoanalyzer (Diazyme assay in 
cobas 8000) generated ADA values based on 
the obtained/ observed Galanti and Guisti 
(manual) method values. A significant 
regression equation was found (F (1, 57) = 
143.58, p < 2.2e-16), with an R2 of 0.711. 
Study predicted that autoanalyzer ADA 
levels were found to be equal to 0.7584775 
+ 0.4737348 (ADA estimated by manual 
method). The autoanalyser measured ADA 
value was found to be 0.473 times the value 
obtained by the Galanti and Guisti (manual) 
method of ADA estimation (Figure 2). 
 
 
Figure 1: Band Altman Plot to analyse the agreement between manual and autoanalyzer 
estimated method 
 
Figure 2: Linear regression between manual and autoanalyzer methods of ADA estimation 
 
DISCUSSION  
ADA, one of the key enzymes of purine 
catabolism involved in the deamination of 
adenosine, plays a major physiological role in 
cell mediated immune response by regulating 
the normal metabolism, proliferation and 






























Manual (Galanti and Guisti) method value 
Linear Regression between the two metods of estimation
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necessary for proliferation and differentiation of 
T lymphocytes and monocyte and macrophage 
and ADA is indispensable requirement for 
development, differentiation and proliferation of 
these key components of the immune system 
cells (12,13) which explains the pathology of 
SCID. Further, increased serum/fluid ADA is 
implicated in several diseases involving 
stimulation of cell mediated immunity such as 
tuberculosis, pleurisy, tubercular meningitis, 
typhoid fever, infectious mononeucleosis and 
bronchogenic carcinoma, etc (16).            
           Tuberculosis remains a significant public 
health hazard in India (9,11). Despite the huge 
advances in the diagnostic techniques for the 
diagnosis of TB, the challenge of developing a 
novel, cost-effective, accurate biomarker-based 
point of care test still prevails. Several 
diagnostic methods such as tuberculin skin test, 
interferon-γ release assay, imaging method, 
pleural biopsy, X-ray, ultrasonography, routine 
thoracic fluid inspection, the highly sensitive 
PCR and bacterial culture have been exploited 
(11,15,17). Rapid definitive diagnosis of TB still 
remains a challenging area with literature 
evidences emphasizing the utility of ADA in the 
diagnosis of TB (12-14). Further, CSF ADA 
shows a high positive predictive value for ADA 
test in diagnosis of tuberculous meningitis and 
ADA has emerged to be a transpicuous and 
rapid test in the diagnosis of TBM with 
sensitivity of 0.89, specificity of 0.91 and AUC 
of 0.96 indicating a sufficient level for 
diagnostic accuracy (18). With TB and its varied 
forms being a group of progressive pathologies 
with severe manifestations and complications 
and causing considerable mortality and severe 
neurological morbidity, early diagnosis remains 
indispensable for rapid treatment and remission 
and ADA indeed offers an immense potential as 
an adjunct diagnostic tool for TB and other 
ADA related pathologies (15,18,19). 
Our study showed that though the manual 
assay technique yielded higher ADA values that 
the autoanalyzer method, yet introduction of a 
correction factor of 2.44 could make both the 
values agreeable. Further, both the methods 
agreed in their direction of shift (increase or 
decrease) with PTB and other pulmonary 
aetiologies showing maximum agreement in 
elevation of ADA level. The Band Altmann plot 
showed agreement of the two analytical 
techniques in almost 90% of the samples. In 
certain conditions, there was an increase in 
autoanalyser and manual values, and it was 
noted that many of these conditions were 
involved with the respiratory system and both 
autoanalyser and annual methods were 
extremely high and proportionate to each other.  
However, for a small proportion of 
samples, the results from two methods were 
highly disparate and application of the 
correction factor did not seem to address the 
observed discrepancy. Though we could not 
arrive at a definite reason for this discrepancy 
observed, it is interesting to note that all these 
samples were derived from patients suffering 
predominantly from non-infectious conditions 
and having very low or high ADA values (as 
obtained from the standard autoanalyzer 
method). The observed discrepancy could be due 
to the sample type (serum/CSF/pleural fluid/ 
ascitic fluid), the stage of disease at which the 
assay was performed, the treatment history or 
interferences specific to the manual assay 
technique used. The study is limited by its small 
sample size and absence of follow-up data. 
Further, the study did not make any stratified 
classification of results based on the type of 
sample (CSF, Ascitic, pleural fluid) analysed 
and assess the agreement of the two methods 
specific to each sample type.  
The study needs to be replicated with a 
larger sample size and a stratified model to make 
definitive conclusions about the alternative 
manual assay method for ADA. Further, sample 
type (serum/ CSF/ pleural fluid/ ascitic fluid) 
specific sensitivity, specificity and limits of 
detection also need to be investigated in future 
studies. However, the study definitely shows the 
huge potential of using an alternative cost 
effective, feasible manual technique of ADA 
analysis, the test being inexpensive, relatively 
non-invasive (compared to invasive conclusive 
tests like ADA), less time consuming, rapid and 
reliable. This could make huge difference in 
analytical and diagnostic approaches in primary 
healthcare setups of developing countries like 








India where incidence of PTB and tuberculous 
meningitis is high.  
Thus, we conclude that Galanti and Guisti 
manual method of ADA estimation might be a 
feasible, transpicuous and rapid test with high 
aggregability to the autoanalyzer method and 
hence reliable for diagnosis  of conditions like 
PTB and TBM. The cost of the cobas 6000/ 
autoanalyzer based diazyme method is higher 
than the manual method. However, many labs do 
not have such facilities and hence could resort to 
the manual method for this investigation. 
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